Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person15
AMERICAN EXPRESS CO
Company
American Well Corp
Company
AMERICAN EXPRESS CREDIT ACCOUNT MASTER TRUST
Company
AMERICAN STATES WATER CO
Company
American Resources Corp
Company
AMERICAN EXPRESS RECEIVABLES FINANCING CORP III LLC
Company
American Bitcoin Corp.
Company
ATLANTIC AMERICAN CORP
Company
REX AMERICAN RESOURCES Corp
Company
AMERICAN ELECTRIC POWER CO INC
Company
AMERICAN TOWER CORP /MA/
Company
AMERICAN VANGUARD CORP
Company
AMERICAN BATTERY TECHNOLOGY Co
Company
AMERICAN CENTURY ETF TRUST
Company
GENERAL AMERICAN INVESTORS CO INC
Company
Primary record15
AMERICAN EXPRESS CO filed 4
SEC form 4 filed by AMERICAN EXPRESS CO (CIK 4962) on 2026-11-06.
Black Spade Acquisition III Co filed 8-K
Item 1.01 Entry Into A Material Definitive Agreement. First Amendment to Business Combination Agreement As previously disclosed in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the
AMERICAN EXPRESS CO filed 4
SEC form 4 filed by AMERICAN EXPRESS CO (CIK 4962) on 2026-11-03.
AMERICAN EXPRESS CO filed 4
SEC form 4 filed by AMERICAN EXPRESS CO (CIK 4962) on 2026-11-03.
AMERICAN EXPRESS CO filed 4
SEC form 4 filed by AMERICAN EXPRESS CO (CIK 4962) on 2026-11-03.
AMERICAN EXPRESS CO filed 4
SEC form 4 filed by AMERICAN EXPRESS CO (CIK 4962) on 2026-11-03.
AMERICAN EXPRESS CO filed 4
SEC form 4 filed by AMERICAN EXPRESS CO (CIK 4962) on 2026-11-03.
AMERICAN EXPRESS CO filed 4
SEC form 4 filed by AMERICAN EXPRESS CO (CIK 4962) on 2026-11-03.
AMERICAN EXPRESS CO filed 4
SEC form 4 filed by AMERICAN EXPRESS CO (CIK 4962) on 2026-11-03.
AMERICAN EXPRESS CO filed 8-K
Item 8.01 Other Events. Exhibits are filed herewith in connection with the issuance by American Express Company (the “Company”), on October 30, 2026, of $1,500,000,000 aggregate principal amount of 5.447% Fixed-to-Floati
Climb Bio, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 24, 2026, Climb Bio, Inc. (the “Company”) issued a press release announcing initial PrisMN Phase 2 data for budoprutug, its anti-CD19 monoclonal antibody, in primary membran
Climb Bio, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 23, 2026, Climb Bio, Inc. (the “Company”) and Beijing Mabworks Biotech Co., Ltd. (“Mabworks”), issued a press release announcing results for additional Phase 1 data in healt
AMERICAN EXPRESS CO filed 8-K
Item 2.02 Results of Operations and Financial Condition and Item 7.01 Regulation FD Disclosure The following information is furnished under Item 2.02 – Results of Operations and Financial Condition and Item 7.01 – Regula
CEMENTOS PACASMAYO SAA filed SCHEDULE 13D/A
0001104659-26-117872.txt : 20261021 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0001104659-26-039944 0002016373 XXXXXXXX LIVE 3 Common Shares, par value S/1.00 per share 10/21/2026 false 0001221029 15126Q109 CE
AMERICAN EXPRESS CO filed 8-K
Item 7.01 Regulation FD Disclosure American Express Company (the Company ) is hereby furnishing below delinquency and write-off statistics for its U.S. Consumer and U.S. Small Business Card balances held for investment f